)
Visual
test
Nanobiotix
Nanobiotix (NANO) investor relations material
Nanobiotix Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary24 Nov, 2025
Executive summary
Closed a non-dilutive royalty financing with HealthCare Royalty (HCRx) valued up to $71 million, with $50 million upfront and $21 million expected in one year upon meeting conditions.
Advanced the JNJ-1900 (NBTXR3) global development program, including first Phase 1 data in esophageal cancer and transfer of Phase 3 study sponsorship to Johnson & Johnson in most regions.
Progressed the Curadigm Nanoprimer program with new patent filings, pre-clinical data, and external collaborations.
Financial highlights
€20.4 million in cash and cash equivalents as of September 30, 2025.
$50 million upfront payment from HCRx extends cash runway, with an additional $21 million expected, providing cash visibility into early 2028.
Outlook and guidance
Clinical updates expected in 2026 from ongoing or completed JNJ-1900 (NBTXR3) Phase 1 studies in melanoma, lung cancer, pancreatic cancer, and esophageal cancer.
Final and updated data from multiple studies, including those sponsored by MD Anderson, anticipated in 2026.
Detail HCRX repayment structure and EIB role
How does JNJ-1900 MoA support broad applicability?
Outline Curadigm's internal and external strategy
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 5 FebMT
Net income rose to $3.2bn in 2025, with $6.5bn EBITDA and strong shareholder returns. - 5 FebEMBC
Q1 FY26 saw stable revenue, higher net income, improved margins, and reaffirmed guidance. - 5 FebRMR
Q1 2026 net income rose 91% to $12.2M, with strong incentive fees and high liquidity. - 5 FebLIN
Record EPS, strong cash flow, and 6–9% 2026 growth outlook driven by clean energy and capital returns. - 5 FebMKL
Operating income hit $3.2B, with improved insurance profitability and broad-based growth. - 5 FebAPOLLOTYRE
Record revenue, profit growth, major expansion, and improved financial metrics in Q3 FY26. - 5 FebSHEL
$18.5B earnings, $26.1B free cash flow, and $22B+ returned to shareholders in 2025. - 5 FebQGEN
2025 results surpassed guidance; 2026 targets strong growth and margin expansion. - 5 FebBIXT
Polysaccharide antivirals blocking galectin show rapid, broad efficacy and near-term commercialization. - 5 FebEZPW
Net income up 43% and revenue up 19% as acquisitions expanded the store footprint.
Next Nanobiotix earnings date
H2 20252 Apr, 2026
Nanobiotix
Next Nanobiotix earnings date
H2 20252 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Nanobiotix S.A. is a biotechnology company that focuses on developing nanomedicine products for cancer treatment. The company's proprietary technology, NanoXray, involves nanoparticles that enhance the effects of radiotherapy by increasing the absorption of X-rays within cancer cells. This approach is designed to improve the precision and effectiveness of radiotherapy, potentially reducing side effects and improving patient outcomes. Nanobiotix's products are primarily in the clinical stages of development, and the company continues to advance its pipeline for various cancer types. The company is headquartered in Paris, France, and its shares are listed on the Euronext Paris.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage